[Liver transplant at the UMAE 25 IMSS Monterrey].

Liver transplantation is the best treatment for end stage liver diseases. In April 2003, our institution started a Liver Transplantation Program for both pediatric and adults population.
Shown the results of the Liver Transplantation Program in the UMAE 25 Monterrey N.L.
This is a retrospective cohort study of patients with liver transplantation.
A total of 51 liver transplantations have been done in 49 patients with two retrasplantation, 15 in children and 36 in adults. The principal indication for liver transplantation in children was biliary atresia and hepatitis C cirrhosis in adults. The acute renal failure was the main early complication, the acute cellular rejection in the mediate period, and the cardiovascular diseases as late complication related to obesity, metabolic syndrome, diabetes mellitus and hypertension. Overall survival at 1 and 5 years was 57.1 and 54.2%, respectively. During the first three years post-transplantation, the quality of life was good or very good.
Although still a young and perfectible program, the effort of a multidisciplinary team has made possible to perform liver transplantation in two patient populations, pediatric and adults.
AuthorsLaura E Cisneros-Garza, Pedro A López-Hernández, M del Rosario Muñoz-Ramírez, Martha Patricia Castilla-Valdéz, M José Sebastián-Ruiz, Juan Gerardo Carmona-Martínez, Guillermo Alberto Alvarez-Treviño, José Guillermo Martínez-Flores, Ramón Olavide-Aguilar
JournalRevista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición (Rev Invest Clin) Vol. 63 Suppl 1 Pg. 67-72 (Sep 2011) ISSN: 0034-8376 [Print] Mexico
Vernacular TitleTrasplante hepático en la Unidad Médica de Alta Especialidad Núm. 25, IMSS Monterrey.
PMID22916614 (Publication Type: English Abstract, Journal Article)
  • Adult
  • Child
  • Cohort Studies
  • Female
  • Humans
  • Liver Transplantation (adverse effects, statistics & numerical data)
  • Male
  • Mexico
  • Postoperative Complications (epidemiology, etiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: